Chapter 6. Immunologic Disorders Flashcards

1
Q

Darier’s sign

A

urticaria and erythema observed on and around a macule after stroking the lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diffuse cutaneous mastocytosis

  • who gets it
  • what is its typical course
A

skin variant, typical in pediatric patients (normally <3), resolves without progress to systemic mastocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

urticaria pigmentosa (UP)

A

discrete yellow-brown macular-papular or nodular plaque-like lesions with characteristic Darier’s sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

diffuse cutaneous mastocytosis (DCM)

A

diffuse yellow-brown thickened skin, no discrete lesion, usually occurs in patients younger than 3 years of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mastocytoma

A

solitary reddish brown skin lesion that usually presents in the first 3 months of life and frequently resolves on its own

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

telangiectasia macularis eruptiva perstans

A

macular telangiectasia characterized by increased mast cells around dilated capillaries and venules. normally found in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

review “Classification of Systemic Mastocytosis”

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the activating mutation in systemic mastocytosis

A

c-kit (KIT D816V)

  • increased mast cell numbers due to constitutive activation of KIT tyrosine kinase signaling and aberrant expression of antiapoptotic proteins (Bcl-1 and Bcl-2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is molecule is required for mast cell survival

A

stem cell factor - ligand for c-KIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

review “other symptoms of mastocytosis”

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where is the most common site of mast cell infiltration and most useful biopsy site

how are mast cells identified

A

bone marrow

identified by immunohistochemical staining for CD117 (c-kit) and CD2 and or CD25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the diagnostic criteria for cutaneous mastocytosis

A

focal dense mast cell infiltrates (>15 mast cells per cluster) or diffuse mast cell infiltrates (>20 mast cells/hpf) on skin biopsy

c-KIT D816V mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what lab should every patient with severe anaphylaxis following a hymenoptera sting get

A

baseline tryptase (screen for mastocytosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the major criteria for diagnosis of Systemic Mastocytosis

A

biopsy with multifocal, dense infiltrates of mast cells (>15 mast cells in aggregates)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the minor criteria for diagnosis of systemic mastocytosis

A
  1. biopsy with more than 25% of mast cells having spindle-shaped or atypical morphology
  2. detection of c-KIT D816V mutation in bone marrow or extracutaneous organ
  3. expression of CD2 and/or CD25 on CD117+ mast cells
  4. total serum tryptase > 20 ng/mL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are major/minor paths to mastocytosis dx

A

1 major + 1 minor

–or–

3 minor

17
Q

MCAS

A

for patients who have a variety of symptoms suggestive of mast cell activation, but who fail to meet the WHO criteria for diagnosis

tryptase = 120% of baseline + 2 with exacerbation of symptoms

so, patient with baseline tryptase of 10 –> 1.20(10)+2 = 14 would meet criteria

18
Q

what is monoclonal mast cell activation syndrome

A

distinguished from MCAS by the presence of the c-KIT D816V mutation, but does not meet full WHO criteria for SM

19
Q

what are lifestyle treatments for MCAS/mastocytosis

A

avoid triggers (alcohol, NSAIDs, narcotics, intense exercise, stinging insects)

antihistamines (first and second generation, H2 blockers)

disodium cromoglycate (gastrochrom)

epinephrine

topical steroids for UP or DCM

cytoreductive treatment –> imatinib (Gleevac) with aggressive systemic symptoms but who lack the c-KIT mutation

DEXA scanning and calcium supplementation

treat other hematologic disorders

20
Q

What cytokine is required for eosinophilic infiltration of the esophagus

A

IL-5

21
Q

What cytokine, important in EoE, is induced by IL-13

A

eotaxin 3

22
Q

What is overexpressed in EoE biopsy tissue (besides eosinophils themselves)

A

TSLP

23
Q

When should biopsy be done for EoE

A

Ideally, 8 weeks after a PPI to help exclude PPI-responsive esophageal eosinophilia

24
Q

Whats the deal with skin prick testing in EoE

A

NPV is high for less common foods (potato, chicken, peanut, beef, pork, corn)

NPV pretty good (80-90%) for egg, wheat, and soy

NPV <30% for milk

PPV is good for milk (86%) but bad for everything else

25
Q

X linked SCID is associated with defects in the so-called “common gamma chain”. What ILs are affected with the common gamma chain

A

IL-2, IL-4, IL-7, IL-9, IL-15, IL-21

26
Q

review features of VCFS/DiGeorge

A
27
Q

what is the clinical triad and mutation in XLP (X-linked lymphoproliferative syndrome)

A

fatal mono, dysgammaglobulinemia, lymphoproliferative disorders

mutation in SLAM-associated protein (SAP gene)

28
Q

Kabuki syndrome

A

mutation of KMT2D –> hypogammaglobulinemia + cleft palate, abnormal facies, developmental delay

think Kabuki theater

29
Q

what is CVID + thymoma called

A

Good syndrome –> red cell aplasia, neutropenia, and chronic diarrhea

30
Q

what flow cytometry changes are associated with hematologic autoimmune complications of CVID

A

low switched memory B cells